Editor's Note A Republican-led House subcommittee investigating the COVID-19 pandemic released a 520-page final report summarizing its two-year inquiry, outlining recommendations for future pandemic preparedness and critiquing both US and global responses to the crisis. CNN reported the news December 2. The report concludes that COVID-19 most likely emerged from…
Editor's Note Researchers at the University of British Columbia (UBC) say their newly created coating could enhance the safety of medical devices by reducing the risks of thrombosis and excessive bleeding in patients. As reported November 30 in Fox News, researchers' findings, published in the journal Nature Materials, highlight how…
Editor's Note The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has initiated a pilot program to improve the speed of public notifications regarding high-risk medical device recalls. According to a November 21 announcement, this initiative aims to minimize the time between the FDA's awareness…
Editor's Note Cardiothoracic surgeons at Emory University Hospital have conducted the first US implantation of the BrioVAD System, a new ventricular assist device (VAD) from BrioHealth Solutions, Cardiovascular Business News reported November 25. According to the article, the BrioVAD System features a magnetically suspended, hemocompatible pump designed to minimize adverse…
Editor's Note A scoping review of 15 studies reveals that the COVID-19 pandemic significantly disrupted oncological abdominal surgery (OAS), leading to postponed or canceled procedures, adoption of alternative treatment plans, and increased psychological stress among surgical teams. Published November 5 in the American Journal of Surgery, the findings emphasize the…
Editor's Note Research reveals combining non-steroidal anti-inflammatory drugs (NSAIDs) with blood thinners heightened bleeding risk across multiple organ systems, HealthDay reported November 18. The study analyzed nearly 52,000 Danish patients prescribed blood thinners between 2012 and 2022, examining NSAID interactions with multiple anticoagulants including rivaroxaban, apixaban, dabigatran, edoxaban, and warfarin.…
Editor's Note Hospitals’ financial outlook is stable, although growth is slowing and certain costs are projected to increase, particularly for cybersecurity, according to two recent Becker’s reports on data from Moody’s Investor Services. The first, published November 14 in Becker’s Hospital CFO Report, notes that “hospitals are facing a stable…
Editor's Note A nationwide shortage of intravenous (IV) fluids is forcing hospitals to adopt conservation strategies that could reshape hydration practices long-term, KFF Health News reported November 19. The shortage was driven by Hurricane Helene’s damage to Baxter International’s North Cove facility, which is responsible for 60% of US IV…
Editor's Note The US Food and Drug Administration (FDA) has designated Class 1 recalls—the most severe category indicating risk of serious injury or death—involving three systems: Atlan anesthesia workstations from Draeger, CADD-Solis ambulatory infusion pumps from Smiths Medical, and Trilogy Evo ventilators from Philips Respironics. FDA issued all three announcements…
Eliminating physical distance as a barrier to communication makes it easier for caretakers to help not only their patients, but also one another. This is the promise of virtual care technology, which offers system-wide potential for providers facing growing demand for high-quality, cost-effective care. For perioperative leaders specifically, advantages of…